Amylyx Pharmaceuticals, Inc. (AMLX)
AMLX Stock Price Chart
Explore Amylyx Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze AMLX price movements and trends.
AMLX Company Profile
Discover essential business fundamentals and corporate details for Amylyx Pharmaceuticals, Inc. (AMLX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Jan 2022
Employees
123.00
Website
https://amylyx.comCEO
Joshua B. Cohen
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
AMLX Financial Timeline
Browse a chronological timeline of Amylyx Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Mar 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.45.
Earnings released on 7 Aug 2025
EPS came in at -$0.46 falling short of the estimated -$0.44 by -4.55%.
Earnings released on 8 May 2025
EPS came in at -$0.42 surpassing the estimated -$0.45 by +6.67%.
Earnings released on 4 Mar 2025
EPS came in at -$0.55 falling short of the estimated -$0.49 by -12.24%, while revenue for the quarter reached -$665.00K .
Earnings released on 7 Nov 2024
EPS came in at -$0.53 falling short of the estimated -$0.47 by -12.77%, while revenue for the quarter reached $416.00K .
Earnings released on 8 Aug 2024
EPS came in at -$0.73 falling short of the estimated -$0.38 by -92.11%, while revenue for the quarter reached -$1.02M , missing expectations by -109.59%.
Earnings released on 9 May 2024
EPS came in at -$0.46 falling short of the estimated $0.24 by -291.67%, while revenue for the quarter reached $88.64M , missing expectations by -9.87%.
Earnings released on 22 Feb 2024
EPS came in at $0.07 falling short of the estimated $0.23 by -69.57%, while revenue for the quarter reached $108.45M , beating expectations by +1.39%.
Earnings released on 9 Nov 2023
EPS came in at $0.30 falling short of the estimated $0.44 by -31.82%, while revenue for the quarter reached $102.69M , missing expectations by -4.78%.
Earnings released on 10 Aug 2023
EPS came in at $0.31 surpassing the estimated $0.10 by +210.00%, while revenue for the quarter reached $98.22M , beating expectations by +6.63%.
Earnings released on 11 May 2023
EPS came in at $0.02 surpassing the estimated -$0.24 by +108.33%, while revenue for the quarter reached $71.43M , missing expectations by -18.47%.
Earnings released on 13 Mar 2023
EPS came in at -$0.65 surpassing the estimated -$0.77 by +15.58%, while revenue for the quarter reached $21.89M , missing expectations by -62.90%.
Earnings released on 10 Nov 2022
EPS came in at -$0.92 surpassing the estimated -$0.97 by +5.15%, while revenue for the quarter reached $345.00K , beating expectations by +314.00%.
Earnings released on 11 Aug 2022
EPS came in at -$0.93 falling short of the estimated -$0.92 by -1.09%.
Earnings released on 12 May 2022
EPS came in at -$0.93 falling short of the estimated -$0.75 by -24.00%.
Earnings released on 30 Mar 2022
EPS came in at -$4.15 falling short of the estimated -$0.64 by -548.44%.
Earnings released on 10 Jan 2022
EPS came in at -$0.42 , while revenue for the quarter reached $285.00K .
Earnings released on 30 Jun 2021
EPS came in at -$0.48 .
Earnings released on 31 Mar 2021
EPS came in at -$0.32 .
Earnings released on 31 Dec 2020
EPS came in at -$0.19 , while revenue for the quarter reached $350.00K .
AMLX Stock Performance
Access detailed AMLX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.